Torrent Pharmaceuticals is recalling 14 lots of tablets used for treatment of high blood pressure and heart failure from the US market due to presence of impurity. The voluntarily recall of Valsartan/ Amlodipine/ HCTZ tablets to the consumer level is due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Zhejiang Huahai Pharmaceuticals.
Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.
